Literature DB >> 106869

The pathology of untreated and antibiotic-treated experimental tularaemia in monkeys.

A Baskerville, P Hambleton, A B Dowsett.   

Abstract

Grivet monkeys were infected intranasally with the virulent Schu-S4 strain of F. tularensis. One group of animals remained untreated and two other groups received a 7-day course of kanamycin therapy starting on either the third or fourth day after infection. Untreated monkeys developed pyrexia and mucopurulent oculonasal discharge and died 5--7 days after infection. All had pyogranulomatous lesions in the liver, spleen, respiratory tract and lymph nodes. Electron microscopy of liver and spleen showed phagocytosis of F. tularensis organisms by macrophages and polymorphonuclear leucocytes, but many bacteria survived phagocytosis and were released on destruction of the cells. Kanamycin therapy enabled most monkeys to survive the disease, but it did not prevent the development of persistent lesions in all animals. Caseous nodules were larger and more widespread in the organs of monkeys in which treatment was delayed until the fourth day of infection.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 106869      PMCID: PMC2041399     

Source DB:  PubMed          Journal:  Br J Exp Pathol        ISSN: 0007-1021


  10 in total

1.  PATHOGENESIS OF EXPERIMENTAL RESPIRATORY TULAREMIA IN MONKEYS.

Authors:  J D WHITE; J R ROONEY; P A PRICKETT; E B DERRENBACHER; C W BEARD; W R GRIFFITH
Journal:  J Infect Dis       Date:  1964-06       Impact factor: 5.226

2.  An analysis of forty-two cases of laboratory-acquired tularemia. Treatment with broad spectrum antibiotics.

Authors:  E L OVERHOLT; W D TIGERTT; P J KADULL; M K WARD; N D CHARKES; R M RENE; T E SALZMAN; M STEPHENS
Journal:  Am J Med       Date:  1961-05       Impact factor: 4.965

3.  Roentgenographic manifestations of pulmonary tularemia.

Authors:  E L OVERHOLT; W D TIGERTT
Journal:  Radiology       Date:  1960-05       Impact factor: 11.105

4.  Studies on human infection with Pasteurella tularensis; comparison of streptomycin and chloramphenicol in the prophylaxis of clinical disease.

Authors:  F R McCRUMB; M J SNYDER; T E WOODWARD
Journal:  Trans Assoc Am Physicians       Date:  1957

5.  AEROSOL INFECTION OF MAN WITH PASTEURELLA TULARENSIS.

Authors:  F R McCrumb
Journal:  Bacteriol Rev       Date:  1961-09

6.  Ultrastructure of phagocytosis of Salmonella cholerae-suis by pulmonary macrophages in vivo.

Authors:  A Baskerville; C Dow; W L Curran; J Hanna
Journal:  Br J Exp Pathol       Date:  1972-12

7.  Antibiotic prophylaxis and therapy of airborne tularemia.

Authors:  W D Sawyer; H G Dangerfield; A L Hogge; D Crozier
Journal:  Bacteriol Rev       Date:  1966-09

8.  Evaluation of a new technique for the demonstration of gonococci and other micro-organisms in host cells.

Authors:  C Sowter; Z A McGEE
Journal:  J Clin Pathol       Date:  1976-05       Impact factor: 3.411

9.  Changes in whole blood and serum components of grivet monkeys with experimental respiratory Francisella tularensis infection.

Authors:  P Hambleton; A Baskerville; P W Harris-Smith; N E Bailey
Journal:  Br J Exp Pathol       Date:  1978-12

10.  Pathogenesis and pathology of respiratory tularaemia in the rabbit.

Authors:  A Baskerville; P Hambleton
Journal:  Br J Exp Pathol       Date:  1976-06
  10 in total
  7 in total

1.  Changes in whole blood and serum components of grivet monkeys with experimental respiratory Francisella tularensis infection.

Authors:  P Hambleton; A Baskerville; P W Harris-Smith; N E Bailey
Journal:  Br J Exp Pathol       Date:  1978-12

2.  The Natural History of Pneumonic Tularemia in Female Fischer 344 Rats after Inhalational Exposure to Aerosolized Francisella tularensis Subspecies tularensis Strain SCHU S4.

Authors:  Julie A Hutt; Julie A Lovchik; Alexander Dekonenko; Andrew C Hahn; Terry H Wu
Journal:  Am J Pathol       Date:  2016-12-08       Impact factor: 4.307

3.  Identification of immunologic and pathologic parameters of death versus survival in respiratory tularemia.

Authors:  Damiana Chiavolini; Joseph Alroy; Carol A King; Peter Jorth; Susan Weir; Guillermo Madico; John R Murphy; Lee M Wetzler
Journal:  Infect Immun       Date:  2007-11-19       Impact factor: 3.441

4.  Establishment of lethal inhalational infection with Francisella tularensis (tularaemia) in the common marmoset (Callithrix jacchus).

Authors:  Michelle Nelson; Mark S Lever; Victoria L Savage; Francisco Javier Salguero; Peter C Pearce; Daniel J Stevens; Andrew J H Simpson
Journal:  Int J Exp Pathol       Date:  2009-04       Impact factor: 1.925

5.  Molecular immunology of experimental primary tularemia in mice infected by respiratory or intradermal routes with type A Francisella tularensis.

Authors:  J Wayne Conlan; Xigeng Zhao; Gregory Harris; Hua Shen; Mark Bolanowski; Cecilia Rietz; Anders Sjostedt; Wangxue Chen
Journal:  Mol Immunol       Date:  2008-03-05       Impact factor: 4.407

Review 6.  Adaptive Immunity to Francisella tularensis and Considerations for Vaccine Development.

Authors:  Lydia M Roberts; Daniel A Powell; Jeffrey A Frelinger
Journal:  Front Cell Infect Microbiol       Date:  2018-04-06       Impact factor: 5.293

7.  Protective effects of the Francisella tularensis ΔpdpC mutant against its virulent parental strain SCHU P9 in Cynomolgus macaques.

Authors:  Deyu Tian; Akihiko Uda; Yasushi Ami; Akitoyo Hotta; Eun-Sil Park; Noriyo Nagata; Naoko Iwata-Yoshikawa; Akio Yamada; Kazuhiro Hirayama; Kozue Miura; Yuki Koyama; Mika Azaki; Shigeru Morikawa
Journal:  Sci Rep       Date:  2019-06-24       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.